Fundraising Fox

CBA Pharma

Lexington, US · Founded 2012 · Nevada corporation

Biotech

Founders & leadership

GP
George P. Julius, Jr.Named on SEC filing
SW
Stephen WhitmanNamed on SEC filing
LC
Louis CarmichaelNamed on SEC filing
SL
Shelden LeBronNamed on SEC filing
LS
Lawrence S. MartiniNamed on SEC filing
RK
Robert K. Oldham, MDNamed on SEC filing
SM
Scott McKinneyNamed on SEC filing
BD
Beth Diane GudemanNamed on SEC filing
WM
W. Michael PutnamNamed on SEC filing
RG
Robert Granacher, Jr., MD, MBANamed on SEC filing
SD
Scott D. McKinneyNamed on SEC filing
SL
Stephen L. WhitmanNamed on SEC filing

Reported raises · per SEC filings

Form D private placements

$639.1K disclosed across 2 rounds · 2012–2015

▶$100KraisedJan 2015 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • George P. Julius, Jr.Executive Officer, Director
  • Stephen WhitmanExecutive Officer, Director
  • Louis CarmichaelExecutive Officer
  • Shelden LeBronExecutive Officer
  • Lawrence S. MartiniExecutive Officer
  • Robert K. Oldham, MDExecutive Officer
  • Scott McKinneyExecutive Officer, Director
  • Beth Diane GudemanExecutive Officer, Director, Promoter
  • W. Michael PutnamExecutive Officer, Director, Promoter
  • Robert Granacher, Jr., MD, MBADirector
Offering amount
$20M
Amount sold
$100K
Proceeds to insiders
$500K
First sale
Jan 2015
Incorporated
Corporation, Nevada, 2012
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$539.1KraisedFeb 2012 · 41 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Scott D. McKinneyExecutive Officer, Director
  • Stephen L. WhitmanDirector
  • W. Michael PutnamExecutive Officer, Director, Promoter
  • Beth GudemanExecutive Officer, Director, Promoter
  • Lawrence S. MartiniExecutive Officer
  • Shelden LeBronExecutive Officer
  • Robert P. Granacher, Jr., MD, MBADirector
  • George P. Julius, Jr.Executive Officer, Director
  • Robert K. Oldham, MDExecutive Officer
Offering amount
$20M
Amount sold
$539.1K
Proceeds to insiders
$450K
First sale
Feb 2012
Incorporated
Corporation, Delaware
Federal exemptions
06
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

How much funding has CBA Pharma raised?
CBA Pharma has disclosed $639.1K raised across 2 rounds.
Where is CBA Pharma headquartered?
CBA Pharma is headquartered in Lexington, US.